West Hertfordshire Integrated Diabetes Service

Concepts

• health services
• west hertfordshire
• welwyn garden city
• west hertfordshire teaching hospital nhs trust
• hertfordshire community nhs trust
• hertfordshire partnership university nhs foundation trust
• west hertfordshire integrated diabetes service
• total cumulative value of this service
• diabetes service
• sub contract elements of the service

Location

Hertfordshire:

Description

This is a Voluntary Ex-Ante Transparency Notice and is intended to provide notice of the Contracting Authority's intention to award a contract for Integrated Diabetes Services within West Hertfordshire. The proposed contract will be awarded to the incumbent provider, West Hertfordshire Teaching Hospital NHS Trust (WHHT), who are the lead provider for a collaborative pathway model and sub contract elements of the service to Hertfordshire Community NHS Trust (HCT) and Hertfordshire Partnership University NHS Foundation Trust (HPFT). The % split of the contract to be provided by sub-contractors is being agreed and is not able to be reflected within this notice.

Total Quantity or Scope

This is a Voluntary Ex-Ante Transparency Notice and is intended to provide notice of the Contracting Authority's intention to award a contract for Integrated Diabetes Services within West Hertfordshire. The proposed contract will be awarded to the incumbent provider, West Hertfordshire Teaching Hospital NHS Trust (WHHT), who are the lead provider for a collaborative pathway model and sub contract elements of the service to Hertfordshire Community NHS Trust (HCT) and Hertfordshire Partnership University NHS Foundation Trust (HPFT). The service provides specialist diabetes care for patients aged 19 years and over for patients with Type 1 and Type 2 Diabetes, but will work with the Paediatric Diabetes service to ensure appropriate and safe transition for all patients moving away from the paediatric service into the Integrated Diabetes Service. The treatment will be over varying lengths of time, according to the clinical needs of the person with diabetes. In ordinary circumstances, this support will be available on an intermittent basis only as the prevailing ethos should be to provide competent self-care and independence with support from primary and community based care. The new proposed contract will be for a period of 12 months with the option to extend for a further 12 months. The new contract will start on 1st April 2023 and will end on 31st March 2024 with the option to extend from 1st April 2024 to 31st March 2025. The contract began in April 2018, the total cumulative value of this service since it began is £21,226,708 (not including VAT or the value of the new proposed contract). The value of this contract, without the optional extension is £4,648,390 (excluding VAT), the total potential value including the optional extension is £9,296,780 (excluding VAT). The figure reflected in this notice is the contract value including the option to extend. Additional information: In line with best practice, the Authority will apply a voluntary 10-day standstill period from the publication date of this notice before awarding the contract, pursuant to Regulation 99 (3) (c) of the Public Contract Regulations 2015 (as amended (EU Exit) 2020 etc.).

Award Detail

Renewal Options

Option to extend for a further 12 months.

Award Criteria

CPV Codes

• 85100000 - Health services

Indicators

• Options are available.

Legal Justification

The Hertfordshire and West Essex Integrated Care Board (HWE ICB) became a legal entity on 1st July 2022, replacing the previous Hertfordshire and West Essex Clinical Commissioning Groups. The organisation is in its early stages and is forming its commissioning and procurement strategies. It is the intention of the HWE ICB to undertake a full commissioning review of its diabetes services within Hertfordshire. To procure services at this stage would risk destabilisation and misalignment to the wider strategy. This short-term extension will allow the HWE ICB time to ensure that a robust strategic review is undertaken which will inform the longer-term decision on how these services will be delivered in future for the benefit of our patients.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **